Rubedo LIfe Sciences, Inc., DBA Rubedo LIfe Sciences, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 17
Rang # Quantité totale PI 88 815
Note d'activité PI 2,1/5.0    18
Rang # Activité PI 46 556
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

8 2
2 0
5 0
0
 
Dernier brevet 2024 - Gpx4 inhibitors and senolytic co...
Premier brevet 2019 - Senolytic compositions and uses ...
Dernière marque 2021 - ALEMBIC
Première marque 2019 - RUBEDO LIFE SCIENCES

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Gpx4 inhibitors and senolytic compounds and uses thereof. The present invention relates to compo...
Invention Gpx4 inhibitors and senolytic compounds and uses thereof. The present invention relates to compou...
Invention Drug conjugates of sugar derivatives and uses thereof as senolytic agents. Provided herein are a...
Invention Sugar derivatives and uses thereof to prepare novel senolytic agents. Provided herein are novel ...
2023 Invention Senolytic compositions and uses thereof. Provided herein are senolytic agents for selectively ki...
2022 Invention Coumarin derivatives of sugar analogs and uses thereof. Provided herein are coumarin derivatives...
Invention Sugar derivatives and uses thereof to prepare novel senolytic agents. Provided herein are novel s...
Invention Drug conjugates of sugar derivatives and uses thereof as senolytic agents. Provided herein are ag...
Invention Coumarin derivatives of sugar analogs and uses thereof. Provided herein are coumarin derivatives ...
Invention Novel sugar derivatives and uses thereof to prepare novel senolytic agents. Provided herein are n...
2021 P/S Pharmaceutical research and development; Pharmaceutical research services; Research and developme...
2019 P/S Pharmaceutical products development for medicines that do not treat redness of the skin; Pharmace...
Invention Senolytic compositions and uses thereof. Provided herein are senolytic agents having the formula:...
Invention Senolytic compositions and uses thereof. Provided herein are senolytic agents for selectively kil...